斯帕沙星及其它喹诺酮类和四环素类对沙眼衣原体的体外及体内抗菌活性
摘要
斯帕沙星及其它喹诺酮类和四环素类对沙眼衣原体的体外及体内抗菌活性（３１２５００）浙江省新昌县妇幼保健所许珊珊（３１２５００）浙江省京新制药厂陈见阳沙眼衣原体是引起各种泌尿生殖系统及眼部感染的一类重要病原体。四环素类虽有一些副作用，但多年来经常用于衣原...
出处
《河北医学》
CAS
1998年第5期107-109,共3页
Hebei Medicine
参考文献10
-
1Maeda,H,A.Fujii.K.Nakata.S.Arakawa,and S.Kamidono.1988.In vitro aetivity of T-3262,NY-198.fleroxacin (AM-833:RO23-6240),and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.Antimicrob.Agents Chemother.32:1080-1081.
-
2Nagayama,A.T.Nakano,and H.Taen.1988.Invitro activitiea of ofloxacin and four other new quinolone-carboxylic acids against Chiamydia trachomatis.Antimicrob.Agents Chemother.32:1735-1737.
-
3Sloney.1.H.Chubb,A Ronald,and R.Brunham.1990.In vitro activity of azithromycin,erythromycin,ciprofloxacin and norfioxacin against Neisseria gonorrhoeae,Haemophilus ducreyi,and Chlamydia trachomatis.J.Antimicrob,Chemother.25(Suppl.A):1-5.
-
4Biscoff,W.1986.Ofloxacin:therapeutic results in Chlamydia.Trachomatis urethritis.Infection 14(Suppl.4):S316-S317.
-
5Ignatius.W.F,W Linton,M.Simbul,R Thorup,B.Mclarighlin,V.Rohm,and P.A.Quinn.1987.Treatment of nongonococcal urethritis with ciprofolxacin.Am.J.Med.82(Suppl.4A):311-316.
-
6Nakamura,S,A.Minaml.K,Nakata,N.Kurobe,K.Kouno,Y.Sakaguchi,S.Kashimoto,H.Yoshida.T.Kojima,T.Ohue,K.Fujimoto.M.Nakamura,MIHashimoto,and M.Shimizu.1989.Invftro and in vivo antibacterial activities of AT-410,a new broadspectrum qui-nolone.Antimicrob.Agents Chemother.33:1167-1173.
-
7Nakata,K.H.Maeda,A.Fujii,S.Arakawa, .Umezu,and S.Kamidono.1989.Program Abstr.29th Intersci.Conf.Antimicrob.Agencs Chemother,abstr 1200.
-
8Miller.L.e.and M.L.Tainter.1944.Estimation of the ED50 and its error by means of logarithmic-probit graph.Proc Soc.Exp.Piol.Med.57:261-264.
-
9Litchfield,J.T.and F.Wilcoxon 1949.A simplified method of evaluating dose-effect experiments.J.Pharmaool.Exp.Ther.96:99-113.
-
10Wise,R.Lockley,J.Dent,and M,Webberly.1984.Pharmacokin-etics and tissue penetration of enoxacin.Antimierod.Agents Chemother.26:17-19.
-
1李眉.斯帕沙星的药理和临床应用[J].药学情报通讯,1994,12(2):84-88. 被引量：8
-
2王金生.斯帕沙星的最近动态[J].化学医药工业信息,1994(12):29-30.
-
3袁俊兰,李世海,栾好波.氨茶碱并用药物的相互作用[J].山东医药工业,1995,14(3):38-40.
-
4郭英辉.喹诺酮类抗生素[J].浙江医学情报,1990(2):33-37.
-
5曹书霞,张建业,姬小明,刘宏民.高效液相色谱法测定斯帕沙星注射液[J].色谱,2001,19(5):454-456. 被引量：2
-
6冯光玲,丁金秀.喹诺酮类抗感染药物——斯帕沙星[J].山东医药工业,1999,18(5).
-
7林赴田.氟喹诺酮类抗菌药的药效学研究新进展[J].四川生理科学杂志,1997,19(3):13-16. 被引量：1
-
8冯惠东,王永祥,蒋林波,张永红,谢立新.国产新药盐酸加替沙星的体外杀菌作用[J].中华综合临床医学杂志（北京）,2004,6(3):14-15.
-
9赵贵英.喹诺酮类抗感染药物研究进展[J].中华医学信息导报,1997,0(3):6-6. 被引量：3
-
10刘爱芹,于胜海,沈霞.阿立哌唑的合成工艺[J].齐鲁药事,2005,24(3):166-167. 被引量：2
